Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...

The FDA has issued 30 warning letters to telehealth companies for making false or misleading claims about compounded GLP-1 products on their websites. The letters cite violations including claims ...

A new oral version of the weight loss drug Wegovy has been approved by the FDA, offering a more affordable and accessible ...

Revolutionizing Medical Weight Loss with GLP-1 Therapy Bellingham, United States - February 25, 2026 / Mt. Baker ...

Point32Health has yet to operate in the black since it merged the state’s second- and third-largest insurers, Harvard Pilgrim ...

By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care A new study finds that people who quit weight-loss medications ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

NC Poison Control says it received one or two calls a day, on average, in 2025 for GLP-1 drugs, with 80% of cases involving a ...

Insurers said they had to withdraw coverage because the pricey medicines overwhelmed their budgets, forcing patients to ...

This is the second wave of warning letters sent to telehealth firms since a crackdown on misleading direct-to-consumer ...